Literature DB >> 19366895

Thiopurinemethyltransferase (TPMT) genotype and TPMT activity in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: relation to azathioprine maintenance treatment and adverse effects.

P M Stassen, R P H Derks, C G M Kallenberg, C A Stegeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19366895     DOI： 10.1136/ard.2008.097667

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people.

Authors:  Elizabeth D Ferucci; Kathy J Hurlburt; Marlyn J Mayo; Stephen Livingston; Heike Deubner; James Gove; Julia Plotnik; Brian J McMahon
Journal:  Can J Gastroenterol       Date:  2011-01       Impact factor: 3.522

Review 2.  Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Arno C Hessels; Jan Stephan F Sanders; Abraham Rutgers; Coen A Stegeman
Journal:  Pharmacogenomics J       Date:  2020-07-18       Impact factor: 3.550

3.  Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.

Authors:  Robert G Micheletti; Christian Pagnoux; Roy N Tamura; Peter C Grayson; Carol A McAlear; Renee Borchin; Jeffrey P Krischer; Peter A Merkel
Journal:  Trials       Date:  2020-04-28       Impact factor: 2.279

4.  Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.

Authors:  Arno C Hessels; Abraham Rutgers; Jan Stephan F Sanders; Coen A Stegeman
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.